Medivir names ex-Novartis exec head of commercial operations
This article was originally published in Scrip
Research-based pharmaceutical company, Medivir, which develops drugs for the treatment of infectious diseases, has appointed Henrik Krook as executive vice-president of commercial operations. Mr Krook joins Stockholm, Sweden-based Medivir from Novartis Norway, where he was country manager/commercial director and also the Scandinavian head of a team working with sales and marketing. He will be responsible for the company's commercial activities, where a priority is to build a Nordic organization for the expected launch of hepatitis C drug, simeprevir.
You may also be interested in...
Infographic: There are two CAR-T therapies on the market, both of which secured their first approvals in 2017. The pipeline of autologous and allogeneic CAR-T options is busy with several candidates in clinical studies. However, getting approval is only one part of getting these breakthrough therapies to patients.
Dmitry Kuzmin, managing partner, and Owen Smith, investment director, talk to In Vivo about 4BIO’s approach to venture investing in the biopharma sector: successes, red flags and targets for its second fund.
In the most recent installment of In Vivo's VC Playbook column, former Amgen R&D lead Sean Harper talks exclusively about his new role as a venture capitalist, joining veteran industry investor Beth Seidenberg as co-founder of Los Angeles-based Westlake Village BioPartners.